Literature DB >> 23024857

Vitamin d in cardiovascular disease.

Aalok Patel1, Yang Zhan.   

Abstract

Entities:  

Year:  2012        PMID: 23024857      PMCID: PMC3445284     

Source DB:  PubMed          Journal:  Int J Prev Med        ISSN: 2008-7802


× No keyword cloud information.
DEAR EDITOR, We read with much interest “Vitamin and Mineral Supplements: Do We Really Need Them?” As mentioned in the article, the use of multivitamin supplement is common, with 40–50% of people over the age of 50 using such supplements, resulting in a total sale approaching $28 billion dollars in 2011.[1] Currently, there is much enthusiasm surrounding vitamin D supplementation and its long-term effects on cardiovascular disease. Many recent prospective studies have shown a greater incidence of cardiovascular events among those people with vitamin D deficiency; however, there have been no randomized controlled trials evaluating vitamin D supplementation in primary prevention of predefined cardiovascular events. Fortunately, the VITAL trial (NCT01169259), a randomized controlled primary prevention trial evaluating whether supplementation of 2000 IU of vitamin D3 or 1 g of omega-3 fatty acids reduces the risk of cardiovascular disease, stroke, and cancer in otherwise healthy patients, is currently ongoing.[2] Hopefully, the VITAL trial will help us reach some conclusion about vitamin D and omega-3 fatty acid supplementation.
  2 in total

Review 1.  Vitamin D and cardiovascular risk.

Authors:  Shweta R Motiwala; Thomas J Wang
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

2.  Vitamin and mineral supplements: do we really need them?

Authors:  Farin Kamangar; Ashkan Emadi
Journal:  Int J Prev Med       Date:  2012-03
  2 in total
  1 in total

1.  Vitamin D supplementation in obese Sri Lankan children: a randomized controlled trial.

Authors:  D B D L Samaranayake; S G S Adikaram; N Atapattu; K M D L D Kendaragama; J T N Senevirathne; H D Jayasekera; V P Wickramasinghe
Journal:  BMC Pediatr       Date:  2020-09-05       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.